50
Participants
Start Date
December 31, 2009
Primary Completion Date
May 31, 2013
Study Completion Date
May 31, 2013
certolizumab pegol
certolizumab pegol 200 mg every 2 weeks
certolizumab pegol
certolizumab pegol 400 mg every 2 weeks
certolizumab pegol
certolizumab pegol 400 mg every 4 weeks
certolizumab pegol
certolizumab pegol 400 mg every 2 weeks
RECRUITING
Atlanta Gastroenterology Associates, Atlanta
Collaborators (1)
UCB Pharma
INDUSTRY
Atlanta Gastroenterology Associates
OTHER